245 related articles for article (PubMed ID: 11886266)
1. An antibody that prevents the hemagglutinin low pH fusogenic transition.
Barbey-Martin C; Gigant B; Bizebard T; Calder LJ; Wharton SA; Skehel JJ; Knossow M
Virology; 2002 Mar; 294(1):70-4. PubMed ID: 11886266
[TBL] [Abstract][Full Text] [Related]
2. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
[TBL] [Abstract][Full Text] [Related]
3. Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.
Bizebard T; Gigant B; Rigolet P; Rasmussen B; Diat O; Bösecke P; Wharton SA; Skehel JJ; Knossow M
Nature; 1995 Jul; 376(6535):92-4. PubMed ID: 7596443
[TBL] [Abstract][Full Text] [Related]
4. Energetics of the loop-to-helix transition leading to the coiled-coil structure of influenza virus hemagglutinin HA2 subunits.
Huang Q; Korte T; Rachakonda PS; Knapp EW; Herrmann A
Proteins; 2009 Feb; 74(2):291-303. PubMed ID: 18618705
[TBL] [Abstract][Full Text] [Related]
5. Thermal denaturation of influenza virus and its relationship to membrane fusion.
Epand RM; Epand RF
Biochem J; 2002 Aug; 365(Pt 3):841-8. PubMed ID: 11994048
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid.
Staschke KA; Hatch SD; Tang JC; Hornback WJ; Munroe JE; Colacino JM; Muesing MA
Virology; 1998 Sep; 248(2):264-74. PubMed ID: 9721235
[TBL] [Abstract][Full Text] [Related]
7. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
Edwards MJ; Dimmock NJ
J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus.
Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F
Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378
[TBL] [Abstract][Full Text] [Related]
9. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.
Skehel JJ; Wiley DC
Annu Rev Biochem; 2000; 69():531-69. PubMed ID: 10966468
[TBL] [Abstract][Full Text] [Related]
10. Antigen distortion allows influenza virus to escape neutralization.
Fleury D; Wharton SA; Skehel JJ; Knossow M; Bizebard T
Nat Struct Biol; 1998 Feb; 5(2):119-23. PubMed ID: 9461077
[TBL] [Abstract][Full Text] [Related]
11. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity.
Korte T; Epand RF; Epand RM; Blumenthal R
Virology; 2001 Oct; 289(2):353-61. PubMed ID: 11689057
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of GRAMM low-resolution docking methodology on the hemagglutinin-antibody complex.
Vakser IA
Proteins; 1997; Suppl 1():226-30. PubMed ID: 9485517
[TBL] [Abstract][Full Text] [Related]
13. Full-length influenza hemagglutinin HA2 refolds into the trimeric low-pH-induced conformation.
Swalley SE; Baker BM; Calder LJ; Harrison SC; Skehel JJ; Wiley DC
Biochemistry; 2004 May; 43(19):5902-11. PubMed ID: 15134464
[TBL] [Abstract][Full Text] [Related]
14. Membrane fusion by influenza hemagglutinin.
Skehel JJ; Bizebard T; Bullough PA; Hughson FM; Knossow M; Steinhauer DA; Wharton SA; Wiley DC
Cold Spring Harb Symp Quant Biol; 1995; 60():573-80. PubMed ID: 8824430
[No Abstract] [Full Text] [Related]
15. Single residue deletions along the length of the influenza HA fusion peptide lead to inhibition of membrane fusion function.
Langley WA; Thoennes S; Bradley KC; Galloway SE; Talekar GR; Cummings SF; Varecková E; Russell RJ; Steinhauer DA
Virology; 2009 Nov; 394(2):321-30. PubMed ID: 19755201
[TBL] [Abstract][Full Text] [Related]
16. Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis.
Leikina E; Markovic I; Chernomordik LV; Kozlov MM
Biophys J; 2000 Sep; 79(3):1415-27. PubMed ID: 10969003
[TBL] [Abstract][Full Text] [Related]
17. Structure of influenza haemagglutinin at the pH of membrane fusion.
Bullough PA; Hughson FM; Skehel JJ; Wiley DC
Nature; 1994 Sep; 371(6492):37-43. PubMed ID: 8072525
[TBL] [Abstract][Full Text] [Related]
18. Structural intermediates in the low pH-induced transition of influenza hemagglutinin.
Gao J; Gui M; Xiang Y
PLoS Pathog; 2020 Nov; 16(11):e1009062. PubMed ID: 33253316
[TBL] [Abstract][Full Text] [Related]
19. Morphological changes and fusogenic activity of influenza virus hemagglutinin.
Shangguan T; Siegel DP; Lear JD; Axelsen PH; Alford D; Bentz J
Biophys J; 1998 Jan; 74(1):54-62. PubMed ID: 9449309
[TBL] [Abstract][Full Text] [Related]
20. Deployment of membrane fusion protein domains during fusion.
Bentz J; Mittal A
Cell Biol Int; 2000; 24(11):819-38. PubMed ID: 11067767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
